| Spotlight |
 |
|
The acquisition will provide access to the half-life extended, high-affinity anti-IgE antibody, Exl-111.
|
| Latest news |
|
|
Upon approval, Rocket has been awarded a priority review voucher, which currently fetch around $200m on the secondary market.
|
|
|
The drug can now be prescribed alongside nab-paclitaxel for patients with ovarian cancer who have relapsed between one and three times.
|
|
|
The collaborations will use Simulations Plus software platforms, including ADMET Predictor, GastroPlus, Thales, and MonolixSuite.
|
|
|
A total of 18 vouchers have been issued via the framework despite a lack of clarity on the awarding process.
|
|
|
The Collaboratory leverages the expertise of Ochsner Health’s Neuroscience Institute.
|
|
|
|
